Video

Management of Melanoma During the COVID Era: From Diagnosis to Treatment

In a panel discussion, Penn Medicine experts discuss the management of Melanoma in the context of COVID-19.

Video

Thyroid Cancer, Nodule Management and COVID-19 | Penn Medicine

In this video, a panel of experts from Penn Medicine’s Endocrine Disease team discusses thyroid cancer and nodule management before, during, and after COVID-19.

Video

Managing Patients with Gastrointestinal Cancers During and After COVID 19 | Penn Medicine

A team of Penn Medicine experts discuss managing gastrointestinal oncology patients during and after COVID-19.

Video

Best Practices for Telemedicine: The Provider and Patient Experience | Penn Medicine

On Thursday, April 23rd, C. William Hanson, MD, Chief Medical Information Officer and Mary Elizabeth Deleener, MBA, BSN, RN, Director of Network Telemedicine at Penn Medicine presented Best Practices for Telemedicine: The Provider and Patient Experience.

Video

Lung Cancer During and After COVID-19

Penn cancer specialists review decision-making for lung cancer patients in the context of COVID-19.

Video

Breast Care and Imaging During COVID-19

On Friday, May 15, a live panel discussion featuring a multidisciplinary team of Breast Cancer experts from Penn Medicine including radiology, breast surgery, medical oncology and OB/GYN reviewed the latest in safety and screening protocols, ...

Document

Hepatic Arterial Infusion Chemotherapy for Colorectal Liver Metastases

Surgeons and oncologists within the Department of Surgery at Penn Medicine are using adjuvant hepatic artery infusion chemotherapy with systemic chemotherapy to prevent recurrence in patients with resected colorectal liver metastases...

Document

Enrolling Clinical Trials: Combination ATR and PARP Inhibitor (CAPRI) Trial With AZD6738 and Olaparib in Recurrent Ovarian Cancer

Investigators in the Division of Gynecologic Oncology at Penn Medicine are conducting a clinical trial to investigate combination therapy with olaparib and AZD6738 in women with high grade serous ovarian or primary peritoneal and/or fallopian tube cancer.

News

BCMA-Targeted Immunotherapy Can Lead to Durable Responses in Multiple Myeloma

Randomized trial shows benefit of belantamab mafodotin in relapsed/refractory patients

Sensory Neurons Outside the Brain Drive Autistic Social Behaviors, Penn Study Suggests

Penn Medicine’s University City Office Tower Awarded LEED Silver Certification

Penn Launches Region’s First Center for Translational Neuromodulation

The Gut Shields the Liver from Fructose-Induced Damage

Spending on Charity Care Stalled as Medicaid Expanded

Long-term Use of Muscle Relaxants Has Skyrocketed Since 2005